T-cell immunotherapy tied to 10-year remission in two leukemia patients, study finds

Two people with leukemia achieved remission over a decade after being infused with CAR-T cells, immune cells that had been modified in a lab, according to a new study. The

Related Keywords

Doug Olson ,David Porter ,Joseph Melenhorst ,Novartis Institute For Biomedical Research In Cambridge ,Warnermedia Company ,University Of Pennsylvania ,Cable News Network Inc ,Carl June ,Novartis Institute ,Biomedical Research ,News Network ,Cnn ,Blood Disorders ,Dancer ,Iseases And Disorders ,Xperimentation And Research ,Ealth And Medical ,Leukemia ,Edical Fields And Specialties ,Edical Treatments And Procedures ,Ncology ,Sychology ,Science ,Therapy ,Patient ,Medicine ,Natomy ,Mmunology ,Ytology ,Chronic Lymphocytic Leukemia ,Side Effect ,Pune ,